PharmaLytica 2021 Hyderabad review.

The Divi's laboratory provides Rs 1,500 Cr to set up a manufacturing factory in Andhra Pradesh

December 04, 2020

Drug maker Divi's Laboratories on Tuesday said it has set aside Rs 1,500 crore to set up a new manufacturing facility in Andhra Pradesh. The work on the manufacturing plant would commence from December 7, Divi's Laboratories said in a regulatory filing.

The Unit-III facility will come up in the East Godavari District, Andhra Pradesh, it added. The company will be investing about Rs 1,500 crore out of its internal accruals in a phased manner for the implementation of the plant, the drugmaker said.

Operations are expected to begin over the next 12 to 18 months for the first phase of the project, he added. All necessary licences were granted by the central government and Andhra Pradesh for the implementation of the project, the company said.


This Website Uses Cookies for Google Analytics, to improve your experience and to show you personalized advertising. By using this website you agree to our COOKIES AND PRIVACY POLICY...Learn More